FDA News Briefs for Wednesday, November 27, 2019

These FDA developments came in this week:FDA Approves System for In-Office Tympanostomy TubesOn November 25, 2019, the Food and Drug Administration (FDA) granted approval for the TULA system (Tusker Medical), the first system that allows insertion of tympanostomy...

Cablivi (Caplacizumab-yhdp)

Caplacizumab is a subcutaneously injected biologic agent intended for use as an adjunct to standard care for acquired thrombotic thrombocytopenic purpura. It is a bivalent single-domain anti-von Willebrand factor (VWF) nanobody that inhibits the binding of VWF to...